Accelerating Adoption: Best Practices for Rolling Out a Scientific GenAI Platform in R&D Enterprises

GenAI is transforming pharma R&D, but full-scale adoption remains in its early stages. This session explores key characteristics of a GenAI platform that not only increases the breadth and depth of scientific inquiry, but also allows wider adoption across biomedical teams. We will also dive into key considerations for scaling GenAI across R&D orgs, highlighting actionable insights for driving trust, value and accelerating innovation.